| CXSL1200035 | 人源化抗人TNFα单克隆抗体注射液(CHO细胞) | adalimumab | Injection | Biological Products(1) | New Drug Application | 2012-07-20 | 沈阳三生制药有限责任公司 | Shenyang Sunshine Pharmaceutical Co Ltd | Certificate Issued | 2014-11-21 | view |
| CXSB2200096 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2022-11-08 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSB2101002 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-18 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSL1400074 | 全人源抗人TNF-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2014-09-28 | 武汉生物制品研究所有限责任公司 | Wuhan Institute of Biological Products Co Ltd | Certificate Issued | 2015-09-23 | view |
| CXSL1600065 | 抗TNFα全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-09-02 | 大庆东竺明生物技术有限公司 | DZM Biotech Ltd | Certificate Issued | 2017-05-22 | view |
| CXSL1600064 | 抗人肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-11-10 | 北京绿竹生物技术股份有限公司 | Beijing Lvzhu Biological Technology Co Ltd | Certificate Issued | 2017-11-21 | view |
| CXSL1400098 | 抗人肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-01-19 | 北京绿竹生物技术股份有限公司 | Beijing Lvzhu Biological Technology Co Ltd | Certificate Issued | 2016-05-12 | view |
| CXSB1600010 | 注射用重组人源化抗人肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products | Supplementary Application | 2016-09-05 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-11-17 | view |
| CXSB1600009 | 注射用重组人源化抗人肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products | Supplementary Application | 2016-09-05 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2016-11-17 | view |
| CXSL1200030 | 注射用重组人源化抗肿瘤坏死因子α单克隆抗体 | adalimumab | Injection | Biological Products(1) | New Drug Application | 2012-06-19 | 珠海市丽珠单抗生物技术有限公司 | Livzon Mabpharm INC | Certificate Issued | 2014-03-04 | view |
| J0300782 | 肿瘤坏死因子α单克隆抗体注射剂 | adalimumab | Injection | Biological Products(7) | Import Drug Application | 2004-06-09 | Abbott Laboratories Ltd | Abbott Laboratories Ltd | Certificate Issued | 2004-12-27 | view |
| JYSB0700067 | 肿瘤坏死因子α单克隆抗体注射剂 | adalimumab | Injection | Biological Products | Supplementary Application | 2007-05-11 | 瑞士雅培制药有限公司北京办事处 | Abbott Laboratories SA-Beijing Representative Office | Certificate Issued | 2007-09-18 | view |
| CXSL1300050 | 肿瘤坏死因子α重组全人源单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-08-16 | 吉林康慧生物科技有限公司 | Alphamab Jilin Co Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1600059 | 重组人TNFα单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-09-12 | 海南赛乐敏生物科技有限公司 | Hainan Sailemin Biotechnology Co Ltd | Certificate Issued | 2017-12-21 | view |
| CXSL1300033 | 重组人抗TNF-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2013-05-28 | 百奥泰生物科技（广州）有限公司 | Bio-Thera Solutions Ltd | Certificate Issued | 2016-01-14 | view |
| CXSL1700003 | 重组人抗TNF-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2017-01-19 | 百奥泰生物科技（广州）有限公司 | Bio-Thera Solutions Ltd | Certificate Issued | 2017-09-14 | view |
| CXSL1400002 | 重组人抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2014-02-17 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2016-01-13 | view |
| CXSB1700005 | 重组人抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2017-08-18 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2018-01-17 | view |
| CXSL1400005 | 重组人抗肿瘤坏死因子-α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2014-02-19 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2016-01-13 | view |
| CXSL1600012 | 重组人源化抗肿瘤坏死因子α单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-05-03 | 深圳万乐药业有限公司 | Shenzhen Main Luck Pharmaceuticals INC | Certificate Issued | 2017-07-06 | view |
